IDiyas

For the Inventor, By the Inventor

Shanghai, China

Yilong Zhou

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 6.6

ph-index = 1


Company Filing History:

goldMedal5 out of 118 
 
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 patents

Years Active: 2019-2021

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):
1. 10947245 - Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine for inhibiting toll-like receptor activity (2021-03-16),
2. 10780091 - TLR7 agonist maleate salt, crystalline forms C, D and E thereof, preparation methods and uses of maleate salt and crystalline forms (2020-09-22),
3. 10683296 - TLR7 agonist trifluoroacetate salt and crystalline form B thereof, preparation methods and uses (2020-06-16),
4. 10654856 - Method for preparing pyrrolo[3,2-D]pyrimidine compound, and intermediates thereof (2020-05-19),
5. 10442811 - Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-D] pyrimidin-4-amine, preparation process and use thereof (2019-10-15),

Title: The Innovative Mind of Yilong Zhou

Introduction

Yilong Zhou is a prominent inventor based in Shanghai, China, known for his significant contributions to the pharmaceutical field. With a remarkable portfolio of five patents to his name, he exhibits an outstanding commitment to innovation and scientific advancement.

Latest Patents

Among Yilong Zhou's latest patents is a groundbreaking crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine, aimed at inhibiting toll-like receptor activity. This invention pertains not only to the crystalline form itself but also encompasses methods for its preparation and potential applications in drug development. Additionally, he has developed patents regarding a TLR7 agonist maleate salt, which includes crystalline forms C, D, and E, alongside their respective preparation methods and uses. These innovations demonstrate his dedication to enhancing therapeutic solutions.

Career Highlights

Yilong Zhou is currently associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a leading pharmaceutical company. His work there has been instrumental in advancing the pipelines of novel compounds and creating effective therapeutic agents. His five patents reflect both his expertise and his drive to push the frontiers of pharmaceutical research.

Collaborations

Throughout his career, Yilong has collaborated with esteemed colleagues, including Zhaozhong Ding and Fei Sun. These partnerships have fostered a dynamic environment for innovation and have contributed to the successful realization of their collective research endeavors.

Conclusion

In summary, Yilong Zhou is an exceptional inventor whose work is making a significant impact in the field of pharmaceuticals. With a strong focus on innovative solutions and collaborative efforts, he continues to pave the way for future advancements in medicine, redefining therapeutic possibilities for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…